We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$561M
Cap. Flow
-$5.26M
Cap. Flow %
-0.29%
Top 10 Hldgs %
16.32%
Holding
823
New
371
Increased
67
Reduced
65
Closed
283

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$29.9M
2
EXAS
Exact Sciences
EXAS
+$12.2M
3
FIVE icon
Five Below
FIVE
+$6.65M
4
KSS icon
Kohl's
KSS
+$6.63M
5
BKS
Barnes & Noble
BKS
+$5.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 84.92%
2 Healthcare 4.2%
3 Consumer Discretionary 2.61%
4 Technology 1.71%
5 Energy 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAIN icon
326
PUT
Hain Celestial
HAIN
$56.7M
$1.16M 0.06%
+50,000
New +$964K
LBRT icon
327
CALL
Liberty Energy
LBRT
$3.18B
$1.16M 0.06%
+75,000
New +$1.15M
SGI
328
Somnigroup International
SGI
$13.8B
$1.15M 0.06%
80,000
-320,000
-80% -$4.33M
IMMU
329
CALL
DELISTED
Immunomedics Inc
IMMU
$1.15M 0.06%
59,900
-44,000
-42% -$709K
SIRI icon
330
PUT
SiriusXM
SIRI
$9.95B
$1.13M 0.06%
20,000
+12,000
+150% +$715K
TBPH icon
331
PUT
Theravance Biopharma
TBPH
$885M
$1.13M 0.06%
+50,000
New +$1.27M
SFIX
332
CALL
Stitch Fix
SFIX
$392M
$1.13M 0.06%
+40,000
New +$993K
SFIX
333
PUT
Stitch Fix
SFIX
$392M
$1.13M 0.06%
+40,000
New +$993K
MDGL icon
334
Madrigal Pharmaceuticals
MDGL
$12.1B
$1.13M 0.06%
+9,000
New +$1.12M
THC icon
335
Tenet Healthcare
THC
$21B
$1.12M 0.06%
39,000
+4,000
+11% +$98.8K
ARNA
336
CALL
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.12M 0.06%
+25,000
New +$1.15M
CYH icon
337
Community Health Systems
CYH
$419M
$1.12M 0.06%
+300,000
New +$1.23M
BHC icon
338
Bausch Health
BHC
$2.12B
$1.11M 0.06%
+45,000
New +$1.07M
TVRD
339
Tvardi Therapeutics
TVRD
$23.5M
$1.1M 0.06%
+1,563
New +$936K
PEGI
340
CALL
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$1.1M 0.06%
+50,000
New +$1.04M
GBT
341
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.08M 0.06%
+20,496
New +$1.01M
GBT
342
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.06M 0.06%
+20,000
New +$983K
GBT
343
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.06M 0.06%
+20,000
New +$983K
UAA icon
344
CALL
Under Armour
UAA
$2.13B
$1.06M 0.06%
50,000
MRNS
345
PUT
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.04M 0.06%
62,500
+56,175
+888% +$809K
GSK icon
346
CALL
GSK
GSK
$100B
$1.04M 0.06%
+20,000
New +$999K
INCY icon
347
Incyte
INCY
$24.7B
$1.03M 0.06%
+12,000
New +$976K
OPLN
348
Openlane
OPLN
$4.26B
$1.03M 0.06%
+52,840
New +$996K
RFP
349
CALL
DELISTED
Resolute Forest Products Inc.
RFP
$1.03M 0.06%
+130,000
New +$1.09M
GNRC icon
350
Generac Holdings
GNRC
$10.3B
$1.02M 0.06%
20,000
+10,000
+100% +$522K

Similar funds

Caption Management's Q1 2019 Portfolio in Review

As of Q1 2019, Caption Management held 823 positions worth $1.81B, up 45% from $1.25B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management's Q1 2019 filing shows 371 new, 67 increased, 65 reduced and 283 closed positions. Its largest new stake was Tapestry: 580,000 shares worth $18.8M. The largest sale was Caesars Entertainment, an estimated $29.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 85% of assets, up from 79% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Caption Management's largest Q1 2019 buy was Tapestry: 580,000 shares worth $18.8M.
  • Caption Management added most to Bristol-Myers Squibb in Q1 2019, an estimated $13.2M increase.
  • Caption Management's biggest Q1 2019 reduction was Somnigroup International, cutting an estimated $4.33M.
  • Caption Management fully exited Caesars Entertainment in Q1 2019, selling an estimated $29.9M.
  • Caption Management's ten largest holdings make up 16% of its $1.81B portfolio in Q1 2019.
  • Caption Management opened 371 new positions and closed 283 in Q1 2019.
  • Caption Management's portfolio value rose 45% quarter-over-quarter to $1.81B.

Based on Caption Management's 13F filing for Q1 2019, filed 14 May 2019.